Camurus AB
CAMRF
$61.75
Updated: 24/09/2026, 14:07:23
Market Cap
$3.67B
Sector
Healthcare
Industry
Biotechnology
Country
SE
Stock valuation chart
One-year closing share-price history for CAMRF
Company Profile
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
USD
OTC
CEO: Sven Fredrik Tiberg
Employees: 285
Asset Summaries
Latest generated summaries for CAMRF
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CAMRF.
- Share price
- $61.75
- Market cap
- $3.67B
- Exchange
- OTC
- Currency
- USD
- CEO
- Sven Fredrik Tiberg
- Employees
- 285
- IPO date
- 11/12/2017
- Beta
- 0.519
- Last dividend
- $0.00
- Day range
- $61.75 – $64.00
- 52-week range
- $54.00 – $71.00
- 1-day performance
- 0.00%
- 1-year performance
- 14.35%
- Current drawdown (1Y)
- -13.03%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- SE0007692850
- Created
- 07/12/2025, 03:11:23
- Last update
- 24/09/2026, 14:07:23
Track Camurus AB with an AI analyst
See which prediction-market events move CAMRF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to CAMRF from your Railway `news_articles` table.